Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ENDRA Life Sciences Inc. (NASDAQ: NDRA).

Full DD Report for NDRA

You must become a subscriber to view this report.


Recent News from (NASDAQ: NDRA)

ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Geneva Switzerland on September 20-22, 2018
ENDRA's Breakthrough Thermo Acoustic Enhanced UltraSound (TAEUS) Technology to be Highlighted at the European Association for the Study of the Liver ANN ARBOR, MI / ACCESSWIRE / August 29, 2018 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA), a developer of enhanced ultrasound tec...
Source: ACCESSWIRE
Date: August, 29 2018 08:31
ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q2 2018 Results - Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q2 2018 Earnings Conference Call August 13, 2018 4:30 PM ET Executives Luke Zimmerman – Senior Associate-MZ North America Francois Michelon – Chief Executive Officer Michael Thornton – Chief Technology Officer David Wells &#x...
Source: SeekingAlpha
Date: August, 14 2018 23:30
Endra Life Sciences reports Q2 results
Endra Life Sciences (NASDAQ: NDRA ): Q2 EPS of -$0.47 More news on: Endra Life Sciences Inc, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 14 2018 13:37
ENDRA Life Sciences Reports Second Quarter 2018 Financial Results
Management to Host Conference Call Today at 4:30 p.m. EDT ANN ARBOR, MI / ACCESSWIRE / August 13, 2018 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, reported its financial and operational results for the three and six months en...
Source: ACCESSWIRE
Date: August, 13 2018 16:01
ENDRA Life Sciences Granted Two U.S. Patents For Correcting Fat-Induced Aberrations & Imaging Biological Tissue Structures
ANN ARBOR, MI / ACCESSWIRE / July 31, 2018 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, has been awarded U.S. Patent Number 10,022,107 from the U.S. Patent and Trademark Office (USPTO) for "Method And System For Correcting Fat-Induc...
Source: ACCESSWIRE
Date: July, 31 2018 08:31

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-143.283.203.282.87116,597

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1135,941118,60430.3034Cover
2018-12-102,79939,8097.0311Cover
2018-12-0728,347201,02814.1010Cover
2018-12-0670,313282,92024.8526Cover
2018-12-0422,18358,17738.1302Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NDRA.


About ENDRA Life Sciences Inc. (NASDAQ: NDRA)

Logo for ENDRA Life Sciences Inc. (NASDAQ: NDRA)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $7,820,554 - 05/18/2018
  • Authorized: 50,000,000 - 04/06/2018
  • Issue and Outstanding: 3,923,027 - 04/06/2018

 


Recent Filings from (NASDAQ: NDRA)

Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: September, 05 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: September, 05 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: September, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 17 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: August, 17 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 13 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: August, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 18 2018
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: July, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 02 2018

 

 


Daily Technical Chart for (NASDAQ: NDRA)

Daily Technical Chart for (NASDAQ: NDRA)


Stay tuned for daily updates and more on (NASDAQ: NDRA)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NDRA)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NDRA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NDRA and does not buy, sell, or trade any shares of NDRA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/